Neko Health Secures $700 Million to Expand Diagnostic Scanning

Led by Lightspeed Venture Partners and O.G. Venture Partners, the latest financing round includes participation from Atomico, General Catalyst, and Lakestar. The company currently operates clinics in the UK and Sweden, but is actively preparing to launch its first U.S. location in New York. With over 100,000 scans completed and a waitlist exceeding 350,000 people, the startup is scaling its clinical footprint rapidly.

The platform integrates proprietary scanning hardware with bloodwork and Apple Health data to provide comprehensive health assessments. Co-founder Hjalmar Nilsonne claims this data synchronization provides clinicians with vital real-world context. The technology has already demonstrated tangible clinical impact; Calm founder Alex Tew credited a Neko scan with identifying a malignant mole on his back, allowing for early surgical intervention. As the sector grows, Neko faces emerging competition from entities like MidJourney, which intends to integrate body-scanning into a high-end spa concept in San Francisco by 2027.